DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Jin N, Lubner SJ, Mulkerin DL. , et al.
A phase II trial of a histone deacetylase inhibitor panobinostat in patients with low-grade neuroendocrine tumors.

Oncologist 2016;
21 (07) 785-786

Download Bibliographical Data

Search in:
Access:
Access: